The survivin splice variant survivin-3B is cytoprotective and can function as a chromosomal passenger complex protein.

Knauer SK, Bier C, Schlag P, Dietmaier W, Rödel F, Klein-Hitpass L, Kovács AF, Döring C, Hansmann ML, Lippert B, Hofmann WK, Kunkel M, Brochhausen C, Engels K, Mann WJ, Stauber RH
Cell Cycle, 2007 in press. IF 4,8

Dynamic survivin in head and neck cancer: Molecular mechanism and therapeutic potential.

Lippert BM, Knauer SK, Fetz V, Mann WJ, Stauber RH
Int J Cancer, 2007 in press, Review. IF 4,7

Nuclear and Cytoplasmic Survivin: Molecular Mechanism, Prognostic and Therapeutic Potential.

Stauber RH, Mann WJ, Knauer SK
Cancer Research, 2007 in press. IF 7,6

Survivin’s Dual Role - An Export’s View.

Knauer SK, Mann WJ, Stauber RH
Cell Cycle. 2007 Mar;6(5):518-21. Epub 2007 Mar 21. IF 4,8

Nuclear export is essential for the tumor-promoting activity of survivin.

Knauer SK, Krämer OH, Knösel T, Engels K, Rödel F, Kovács AF, Dietmaier W, Klein-Hitpass L, Habtemichael N, Schweitzer A, Brieger J, Rödel C, Mann W, Petersen I, Heinzel T, Stauber RH.
FASEB J. 2007 Jan;21(1):207-16. Epub 2006 Nov 10. IF 7,064

Dynamic intracellular survivin in oral squamous cell carcinoma: underlying molecular mechanism and potential as an early prognostic marker.

Engels K, Knauer SK, Metzler D, Simf C, Struschka O, Bier C, Mann W, Kovács AF, Stauber RH.
J Pathol. 2007 Apr;211(5):532-40. IF 6,213

The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function.

Knauer SK, Bier C, Habtemichael N, Stauber RH.
EMBO Rep. 2006 Dec;7(12):1259-65. Epub 2006 Nov 10. IF 7,63